Top institutional investors include Pura Vida Investments LLC (1.37%), Jane Street Group LLC (0.24%), Northern Trust Corp (0.19%), ExodusPoint Capital Management LP (0.11%), Archford Capital Strategies LLC (0.05%) and Squarepoint Ops LLC (0.04%). Wall Street analysts have given Bionano Genomics a "Buy" rating, but there may be better short-term opportunities in the market. The upside will depend on … Bionano Genomics' stock is owned by a number of retail and institutional investors. View Bionano Genomics' Short Interest. MarketBeat just released five new trading ideas, but Bionano Genomics wasn't one of them. 4 analysts have issued twelve-month price objectives for Bionano Genomics' stock. While shares are off the fresh 52 This suggests that the stock has a possible downside of 22.0%. BioNano Genomics, Inc NASDAQ Updated Feb 24, 2021 7:29 PM. According to analysts' consensus price target of $7.81, Bionano Genomics has a forecasted downside of 22.0% from its current price of $10.02. Receive a free world-class investing education from MarketBeat. R. Erik Holmlin has an approval rating of 73% among Bionano Genomics' employees. >> As of 2021 February 21, Sunday current price of BNGO stock is 13.580$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). With a 5-year investment, the revenue is expected to be around +212.59%. Get Our PREMIUM Forecast Now, from ONLY $7.49! The firm earned $2.20 million during the quarter, compared to analyst estimates of $2.15 million. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Analyst projections state that BNGO is forecast to be at a low of $0.75 and a high of $2. View our earnings forecast for Bionano Genomics. BNGO stock was purchased by a variety of institutional investors in the last quarter, including Pura Vida Investments LLC, Jane Street Group LLC, ExodusPoint Capital Management LP, Northern Trust Corp, Archford Capital Strategies LLC, Squarepoint Ops LLC, Creative Planning, and BlackRock Inc.. View insider buying and selling activity for Bionano Genomics or or view top insider-buying stocks. Currently, the average revenue forecast for … liable for your own investment decisions and agree to Please log in to your account or sign up in order to add this asset to your watchlist. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. Bionano's stock forecast Being a penny stock , Bionano isn't well covered by analysts. According to . Investors can use this … From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! Only 1.20% of the stock of Bionano Genomics is held by insiders. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The consensus among Wall Street analysts is that investors should "buy" Bionano Genomics stock. Currently, only two analysts cover the stock and both of them have a buy rating. WARNING: Trend forecast is still in the development phase and should be used with caution. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. The company issued 2,500,000 shares at $6.00-$7.00 per share. Based on an average daily volume of 71,690,000 shares, the short-interest ratio is currently 0.4 days. ... Analyst Forecasts. Learn about financial terms, types of investments, trading strategies and more. All users should speak with their financial advisor before buying or selling any securities. Bionano Genomics has received 50.68% “underperform” votes from our community. Did The Underlying Business Drive Bionano Genomics' (NASDAQ:BNGO) Lovely 997% Share Price Gain? Ribbon Communications (NASDAQ: RBBN) Stock Providing Pullback Opportunities, Plug Power Stock is Recharging for Another Run, 3 Dividend Stocks to Help You Sleep Well at Night, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, This Stock Went from Less Than $1 to Above $10 in a Few Weeks, How to Buy Bionano Genomics Inc. (BNGO) Stock, Analyst Pounds the Table on Bionano (BNGO) Stock, Bionano’s Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed, Analyzing Bionano Genomics's Unusual Options Activity. Some companies that are related to Bionano Genomics include Coherent (COHR), Pacific Biosciences of California (PACB), Berkeley Lights (BLI), Quanterix (QTRX), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), EyePoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), Astrotech (ASTC), Precipio (PRPO), Scientific Industries (SCND), HTG Molecular Diagnostics (HTGM), Pressure BioSciences (PBIO), BioForce Nanosciences (BFNH) and Arrayit (ARYC). Identify stocks that meet your criteria using seven unique stock screeners. Financial outlook for BNGO stock in 2021 and beyond. 100% Free, Limited Time Only! 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last year. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. BNGO 11.06 0.84 (8.22%). The P/E ratio of Bionano Genomics is -5.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Bionano Genomics does not currently pay a dividend. Get short term trading ideas from the MarketBeat Idea Engine. Shares of Bionano Genomics (NASDAQ:BNGO) furthered their recent gains on Monday. View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas. Earnings for Bionano Genomics are expected to grow in the coming year, from ($0.43) to ($0.22) per share. Given the current short-term trend, the stock is expected to rise 999.99% during the next 3 months and, with a 90% probability hold a price between $110.22 and $192.00 at the end of this 3-month period. By the close of trading, the genome analysis company's stock price was up 28.4%. The company can be reached via phone at 858-888-7600 or via email at [email protected]. Bionano Genomics' mailing address is 9540 TOWNE CENTRE DRIVE SUITE 100, SAN DIEGO CA, 92121. View which stocks have been most impacted by COVID-19. Bionano Genomics Stock Forecast is based on your current time horizon. Based on our forecasts, a long-term increase is expected, the "BNGO" stock price prognosis for 2026-02-13 is 42.652 USD. Your losses are our losses too. Bionano Genomics has received a consensus rating of Buy. View our full suite of financial calendars and market data tables, all for free. BNGO -- USA Stock : USD 13.57 0.75 5.85% : Bionano Genomics Stock Forecast is based on your current time horizon. 10 employees have rated Bionano Genomics CEO R. Erik Holmlin on Glassdoor.com. The BioNano Genomics Inc. stock price fell by -5.65% on the last day (Thursday, 4th Feb 2021) from $11.85 to $11.18. The company earns $-29,820,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis. Bionano (BNGO) to Report Q4 Earnings: What's in the Offing? BNGO Stock Analysis Overview What this means: Bionano Genomics Inc (BNGO) gets an Overall Rank of 60, which is an above average rank under InvestorsObserver's stock ranking system. Bionano Genomics has only been the subject of 1 research reports in the past 90 days. Unprepared investors always get killed in megatrends. Looking for new stock ideas? View analyst ratings for Bionano Genomics or view top-rated stocks. Please read the full disclaimer here. Learn everything you need to know about successful options trading with this three-part video course. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California. Get the latest Bionano Genomics, Inc. BNGO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. SmartAsset's free quiz matches you with fiduciary financial advisors in your area in 5 minutes. BNGO stock has risen by more than 1,000 percent in over a month, which is a huge movement for a stock. During the day the stock fluctuated 5.36% from a day low at $11.01 to a day high of $11.60. Bionano Genomics' management team includes the following people: 20 Questions To See If You Can Retire Comfortably. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. MarketBeat's community ratings are surveys of what our community members think about Bionano Genomics and other stocks. Best Stocks in the Past Week: Bionano Genomics Surges, Why Bionano Genomics Stock Is Trading Higher Today, view top-rated stocks among Wall Street analysts, Pennsylvania Real Estate Investment Trust (PEI), Receive Analysts' Upgrades and Downgrades Daily. The price has fallen in 6 of the last 10 days, but is still up by 35.19% over the past 2 weeks. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. This time it won’t be different! In the past three months, Bionano Genomics insiders have not sold or bought any company stock. On average, they anticipate Bionano Genomics' stock price to reach $4.44 in the next year. There are currently 1 hold rating and 3 buy ratings for the stock. Start Your Risk-Free Trial Subscription Here, Stocks fall as yields continue to climb; GameStop surges, World shares skid, US futures turn higher after Wall St rout, Tech rout pulls Nasdaq down 3.5%, biggest loss since October, Game on, again: GameStop surges and no one truly knows why, Vaccination 'passports' may open society, but inequity looms, Closing prices for crude oil, gold and other commodities, House to vote on virus bill; arbiter says wage hike a no-go, Guardion Health Sciences Stock Needs to Give Investors More Than Survival, Wait For a Better Price Before Placing a Bet On Churchill Downs, 3 Small Cap Dividend Stocks with Growth Prospects. The official website for Bionano Genomics is www.bionanogenomics.com. Based on aggregate information from My MarketBeat watchlists, some companies that other Bionano Genomics investors own include Matinas BioPharma (MTNB), Gran Tierra Energy (GTE), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Cannabics Pharmaceuticals (CNBX), KushCo (KSHB), Aeterna Zentaris (AEZS) and OrganiGram (OGI). BNGO updated stock price target summary. All rights reserved. BioNano Genomics stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for BNGO in the last 3 months. Bionano Genomics has a P/B Ratio of 91.09. Bionano Genomics, Inc. (BNGO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). View Bionano Genomics' earnings history. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 BNGO stock was sold by a variety of institutional investors in the last quarter, including Triton Wealth Management PLLC, and Proequities Inc.. View insider buying and selling activity for Bionano Genomics or view top insider-selling stocks. Their forecasts range from $1.00 to $15.00. (BNGO) raised $16 million in an IPO on the week of August 20th 2018. Since then, BNGO stock has increased by 1,636.6% and is now trading at $10.02. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Bionano Genomics, Inc. Common Stock (BNGO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Activity in shares has been substantial for a company worth less than $1 billion. By using the site you agree and are held The business earned $2.20 million during the quarter, compared to the consensus estimate of $2.15 million. Sign-up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Bionano Genomics is headquartered at 9540 TOWNE CENTRE DRIVE SUITE 100, SAN DIEGO CA, 92121. featured in The Global Fintech Index 2020 as the top Fintech company of the country. Compare Top Brokerages Here. Terms of Use and Privacy Policy. BNGO stock is up 280% this year as its story begins to unfold. The price target was set to $1.50 → $15.00. 4 Wall Street analysts that have issued a 1 year BNGO price target, the average BNGO price target is $10.94, with the highest BNGO stock price forecast at $15.00 and the lowest BNGO stock price forecast at $0.75. View real-time stock prices and stock quotes for a full financial overview. Do Not Sell My Information. Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. Want to see which stocks are moving? Fundamental company data provided by Zacks Investment Research. View all of BNGO's competitors. About the Bionano Genomics Inc stock forecast Unlock SECRET Features HERE for $1! On average, they anticipate Bionano Genomics' share price to reach $7.81 in the next twelve months. 4 equities research analysts have issued twelve-month target prices for Bionano Genomics' shares. View the latest Bionano Genomics Inc. (BNGO) stock price, news, historical charts, analyst ratings and financial information from WSJ. The reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.02. Bionano Genomics Inc (BNGO) Analyst Forecast Next 12 months MEAN $10.94 -20.17% HIGH $15.00 +9.49% LOW $0.75 -94.53% Current Price $13.70 52-week … Firstly, the revenue outlook for 2021 looks positive according to analyst forecasts. ), Bionano Genomics has received 150 “underperform” votes. The latest BNGO stock news, ARKG updates and 2 major BNGO stock catalysts to watch. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. View which stocks are hot on social media with MarketBeat's trending stocks report. Learn more. Investors can use this forecasting interface to forecast Bionano Genomics historical stock prices and determine the direction of Bionano Genomics's future trends based on various well-known forecasting models. Bionano Genomics, Inc. (NASDAQ:BNGO) posted its quarterly earnings results on Friday, November, 13th. Bionano Genomics (NASDAQ:BNGO) Earnings Information Bionano Genomics last issued its quarterly earnings results on November 13th, 2020. Find real-time BNGO - Bionano Genomics Inc stock quotes, company profile, news and forecasts from CNN Business. NASDAQ:BNGO continued its 2021 momentum as the red-hot genomics sector keeps hitting new highs on a daily basis. (Add your “underperform” vote.). We are all together in this COVID-19 pandemic. Should Fiverr Investors Be Worried About LinkedIn? Roth Capital Partners and Maxim Group acted as the underwriters for the IPO and LifeSci Capital was co-manager. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The price boost had a significant effect on investor sentiment, sending the stock 37% higher. See what's happening in the market right now with MarketBeat's real-time news feed. Their forecasts range from $1.00 to $14.00. and has now fallen 3 days in a row. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. On February 08, 2021 "Oppenheimer" gave "" rating for BNGO. Bionano Genomics saw a increase in short interest in the month of January. Only 5.64% of the stock of Bionano Genomics is held by institutions. View IEX’s Terms of Use. Export data to Excel for your own analysis. In order for the stock price to hit the forecast high, the stock would need to surge -76.28% from its current level, while the stock would need to crash -91.1% from its current level to reach the projected low. You can opt out at any time. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. BNGO | Complete Bionano Genomics Inc. stock news by MarketWatch. Your current $100 investment may be up to $312.59 in 2026. Bionano Genomics had a negative trailing twelve-month return on equity of 749.14% and a negative net margin of 510.42%.
Eddie Bo Smith Jr Movies, Ps4 Remote Play Controller Android 9, Garfield Fire Prevention Bureau Dwelling Certificate, San Antonio News Today, Decorative Post Base Covers,